Status:
COMPLETED
Yoga for Fatigue in the Survivors of Bone Marrow Transplantation
Lead Sponsor:
University of Michigan
Conditions:
Fatigue
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cancer-related fatigue (CRF) after hematopoietic cell transplantation (HCT) is a persistent problem that limits activities and causes distress. Considering the high prevalence of CRF among HCT survivo...
Detailed Description
OBJECTIVES Primary Objective: To assess the feasibility of an organized yoga intervention for HCT survivors with CRF. Hypothesis: A trial of yoga in the HCT survivor population will be deemed feasib...
Eligibility Criteria
Inclusion
- Adult HCT survivors as defined by being at least 100 days post autologous or allogeneic transplantation for a malignant disease. There is no restriction to enrollment by donor type, donor cell source, presence or absence of graft versus host disease.
- Age ≥ 18 years at the time of transplant.
- A history of persistent CRF as defined by a perception of general CRF for at least one month before enrollment.
- A history of at least moderate CRF as defined by a CRF score of 4 or more on a 10-point Visual Analog Scale.
- Participants who are deemed qualified for yoga movements according to the Yoga Qualifying Movements Screening Checklist (a checklist developed by researchers at the University of California, Los Angeles to promote yoga safety through assessing the eligibility of each patient)
Exclusion
- A self-reported current practice of yoga or any other mind-body therapy, including but not limited to meditation or hypnosis therapy in the past 30 days prior to study enrollment.
- Subjects currently on supplemental oxygen support.
- Subjects currently receiving hemodialysis.
- Subjects currently admitted to an inpatient unit at Michigan Medicine.
- Subjects with an uncontrolled, active infection. Subjects with viremia (Cytomegalovirus or other) may be enrolled, provided they are on active therapy and at the discretion of the treating physician.
- Subjects who have relapsed after their autologous or allogeneic transplant.
Key Trial Info
Start Date :
December 22 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03299465
Start Date
December 22 2017
End Date
July 31 2018
Last Update
August 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Center
Ann Arbor, Michigan, United States, 48105